XML 27 R13.htm IDEA: XBRL DOCUMENT
v3.25.3

Note 5 - Earnings Per Common Share | 3 Months Ended
--- | ---
Sep. 30, 2025
Notes to Financial Statements |
Earnings Per Share [Text Block] | NOTE 5 - EARNINGS PER COMMON SHARE The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding:
(in thousands, except per share data) |  | Three Months Ended |
|  | September 30 |
BASIC EARNINGS PER SHARE |  | 2025 |  |  | 2024 |
Net Income |  | $ | 7,264 |  |  | $ | 6,682 |
Weighted average shares outstanding during the period, net of treasury shares |  |  | 29,345 |  |  |  | 28,514 |
Weighted average vested restricted stock units outstanding |  |  | 42 |  |  |  | 90 |
Weighted average shares outstanding in the Deferred Compensation Plan during the period |  |  | 1,062 |  |  |  | 989 |
Weighted average shares outstanding |  |  | 30,449 |  |  |  | 29,593 |
Basic income per share |  | $ | 0.24 |  |  | $ | 0.23 |
DILUTED EARNINGS PER SHARE |  |  |  |  |  |  |  |
Net Income |  | $ | 7,264 |  |  | $ | 6,682 |
Weighted average shares outstanding |  |  |  |  |  |  |  |
Basic |  |  | 30,449 |  |  |  | 29,593 |
Effect of dilutive securities (a): |  |  |  |  |  |  |  |
Impact of common shares to be issued under stock option plans, and Contingently issuable shares, if any |  |  | 932 |  |  |  | 937 |
Weighted average shares outstanding |  |  | 31,381 |  |  |  | 30,530 |
Diluted income per share |  | $ | 0.23 |  |  | $ | 0.22 |
Anti-dilutive securities (b) |  |  | - |  |  |  | 265 |
| (a) | Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.
| (b) | Anti-dilutive securities were excluded from the computation of diluted net income per share for the three months ended September 30, 2024, because the exercise price was greater than the average fair market price of the common shares or because the assumed proceeds from the award’s exercise or vesting was greater than the average fair market price of the common shares.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration